SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?


To: Micawber who wrote (2708)9/29/1999 9:52:00 AM
From: Scott H. Davis  Read Replies (1) | Respond to of 4676
 
Isis and Rhone-Poulenc Rorer Establish Antisense Target Validation Collaboration.

biz.yahoo.com

This could lead to a very positive market response if we get a good 2302 partnership agreement soon, especially if combined with good pres and/or improved analyst coverage. (I've noticed that with announcements like this, that the effect of a single announcement is minimal, but several combined is quite positive. IMSCO Scott